Dr. Robert Lee Gillespie, MD

Dr. Gillespie practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Gillespie's NPI, 1740290873, was assigned on August 9, 2006. Dr. Gillespie graduated from Pritzker School of Medicine in 1986. Dr. Gillespie holds California license G66094.

Dr. Gillespie's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Gillespie's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Gillespie is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Gillespie to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gillespie practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gillespie's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gillespie is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gillespie's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure and heart valve disorders among the conditions Dr. Gillespie treats.

CMS data shows 1,225 Medicare services from Dr. Gillespie across 23 procedure codes in 2024, for 746 Medicare patients. Medicare paid $81,694 for them.

CMS counts 746 Medicare patients who saw Dr. Gillespie in 2024. The largest group is 65 to 74, with 313 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gillespie's median patient age at 66, with 56% women.

In 2024, Dr. Gillespie wrote 3,769 Medicare Part D claims for 591 patients. 77% of them were for generic drugs. CMS names the drug for 3,580 of them, across 45 drugs with 11 or more claims each, at $1,318,083 in total drug cost. In 2023, CMS named 3,525 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gillespie for performance year 2024, reported as part of a group. Dr. Gillespie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Gillespie in 2017. Dr. Gillespie's most frequent co-authors are Icilma V. Fergus, MD, Cathleen Noel Bairey Merz, MD and Angela Dispenzieri, MD.

CMS Open Payments shows 204 general payments to Dr. Gillespie from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Edwards Lifesciences Corporation paid the most, $59,204.

Dmand AI lists 1 award for Dr. Gillespie.

Dr. Gillespie graduated from Pritzker School of Medicine in 1986. Dr. Gillespie is a member of ACC, ASE and ASNC.

Dr. Gillespie is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.